Cargando…
An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection
INTRODUCTION: Intrapleural tissue plasminogen activator (tPA) combined with human recombinant DNase (DNase) could be an effective alternative to surgery in managing pleural infection, as demonstrated in the Multi-centre Intrapleural Sepsis Trial (MIST)-2. However, the optimal delivery regimen is sti...
Autores principales: | Lau, Estee P.M., Eshraghi, Matin, Dootson, Kirstie, Yeoh, Cindy, Ywe Phu, Wint, Lee, Y.C. Gary, Popowicz, Natalia D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819248/ https://www.ncbi.nlm.nih.gov/pubmed/35141321 http://dx.doi.org/10.1183/23120541.00590-2021 |
Ejemplares similares
-
Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection
por: Bédat, Benoît, et al.
Publicado: (2019) -
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
por: Kanellakis, Nikolaos I, et al.
Publicado: (2019) -
Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections
por: McClune, Jason R., et al.
Publicado: (2016) -
Unintentional intramuscular administration of tPA/DNase for pleural infection
por: Popowicz, Natalia, et al.
Publicado: (2014) -
Short-course modified regimen intrapleural alteplase and pulmozyme (DNase) in pleural infection
por: Faisal, M., et al.
Publicado: (2020)